These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25999103)

  • 1. Blood glucose variability: a new metric for interventional cardiology?
    Farkouh ME
    JACC Cardiovasc Interv; 2015 May; 8(6):812-813. PubMed ID: 25999103
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study.
    Kuroda M; Shinke T; Sakaguchi K; Otake H; Takaya T; Hirota Y; Sugiyama D; Nakagawa M; Hariki H; Inoue T; Osue T; Taniguchi Y; Iwasaki M; Nishio R; Kinutani H; Konishi A; Hiranuma N; Takahashi H; Terashita D; Hirata KI
    JACC Cardiovasc Interv; 2015 May; 8(6):800-811. PubMed ID: 25999102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between daily glucose fluctuation and coronary plaque properties in patients receiving adequate lipid-lowering therapy assessed by continuous glucose monitoring and optical coherence tomography.
    Kuroda M; Shinke T; Sakaguchi K; Otake H; Takaya T; Hirota Y; Osue T; Kinutani H; Konishi A; Takahashi H; Terashita D; Uzu K; Hirata K
    Cardiovasc Diabetol; 2015 Jun; 14():78. PubMed ID: 26062762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyslipidemia vs hyperglycemia.
    Feeman WE
    Prev Cardiol; 2007; 10(2):112. PubMed ID: 17392624
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between blood glucose variability and coronary plaque instability in patients with acute coronary syndromes.
    Okada K; Hibi K; Gohbara M; Kataoka S; Takano K; Akiyama E; Matsuzawa Y; Saka K; Maejima N; Endo M; Iwahashi N; Tsukahara K; Kosuge M; Ebina T; Fitzgerald PJ; Honda Y; Umemura S; Kimura K
    Cardiovasc Diabetol; 2015 Aug; 14():111. PubMed ID: 26289581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomography angiography defined vulnerable plaque in a patient with low high-density lipoprotein cholesterol and subsequent myocardial infarction.
    Rached FH; Rocha VZ; Santos RD; Serrano CV; Caixeta A
    Coron Artery Dis; 2017 Dec; 28(8):712-714. PubMed ID: 28704240
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravascular Ultrasound Studies of Plaque Progression and Regression: Impact of Lipid-Modifying Therapies.
    Shishikura D; Honda S; Andrews J; Nicholls SJ
    Cardiol Clin; 2018 May; 36(2):329-334. PubMed ID: 29609762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of combined lipid lowering and blood pressure control on coronary plaque: myocardial ischemia treated by percutaneous coronary intervention and plaque regression by lipid lowering and blood pressure controlling assessed by intravascular ultrasonography (MILLION) study.
    Kawashiri MA; Sakata K; Hayashi K; Gamou T; Kanaya H; Miwa K; Ueda K; Higashikata T; Mizuno S; Michishita I; Namura M; Nitta Y; Katsuda S; Okeie K; Hirase H; Tada H; Uchiyama K; Konno T; Ino H; Nagase K; Yamagishi M;
    Heart Vessels; 2017 May; 32(5):539-548. PubMed ID: 27798731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCSK9: is it fluoride for cardiology?
    King SB
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1331-2. PubMed ID: 25459045
    [No Abstract]   [Full Text] [Related]  

  • 10. A new activity of N-cholinolytic drug benzohexonium.
    Khnychenko LK; Okunevich IV; Losev NA; Sapronov NS; Yakovleva EE
    Bull Exp Biol Med; 2012 Aug; 153(4):487-9. PubMed ID: 22977852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of plaque imaging by electron beam tomography on the treatment of dyslipidemias.
    Hecht HS
    Am J Cardiol; 2001 Aug; 88(4):406-8. PubMed ID: 11545763
    [No Abstract]   [Full Text] [Related]  

  • 12. Current status of lipid management in acute coronary syndrome.
    Fujisue K; Tsujita K
    J Cardiol; 2017 Aug; 70(2):101-106. PubMed ID: 28325524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Statin Versus Statin Plus Ezetimibe for Coronary Plaque Regression.
    Mascitelli L; Goldstein MR
    J Am Coll Cardiol; 2015 Dec; 66(25):2916. PubMed ID: 26718684
    [No Abstract]   [Full Text] [Related]  

  • 14. Impacts of estimated glomerular filtration rate on coronary atherosclerosis and plaque composition before and during statin therapy in patients with normal to mild renal dysfunction: subanalysis of the TRUTH study.
    Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Hibi K; Terashima M; Michishita I;
    Nephrology (Carlton); 2012 Sep; 17(7):628-35. PubMed ID: 22708952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reply: Evaluating Statin Versus Statin Plus Ezetimibe for Coronary Plaque Regression.
    Tsujita K; Sugiyama S; Shimomura H; Yamanaga K; Kaikita K; Hokimoto S; Ogawa H;
    J Am Coll Cardiol; 2015 Dec; 66(25):2916-2917. PubMed ID: 26718685
    [No Abstract]   [Full Text] [Related]  

  • 16. Plaque vulnerability at non-culprit lesions in obese patients with coronary artery disease: Frequency-domain optical coherence tomography analysis.
    Kataoka Y; Hammadah M; Puri R; Duggal B; Uno K; Kapadia SR; Tuzcu EM; Nissen SE; Nicholls SJ
    Eur J Prev Cardiol; 2015 Oct; 22(10):1331-9. PubMed ID: 26232281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglycerides: how much credit do they deserve?
    Kohli P; Cannon CP
    Med Clin North Am; 2012 Jan; 96(1):39-55. PubMed ID: 22391250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI: PRECISE-IVUS.
    Giral P; Hansel B; Chapman J
    J Am Coll Cardiol; 2016 Jan; 67(2):234. PubMed ID: 26791072
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply: Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI: PRECISE-IVUS.
    Tsujita K; Sugiyama S; Shimomura H; Yamanaga K; Kaikita K; Hokimoto S; Ogawa H;
    J Am Coll Cardiol; 2016 Jan; 67(2):234-235. PubMed ID: 26791071
    [No Abstract]   [Full Text] [Related]  

  • 20. Getting What the Guidelines Stated Matters.
    Stone NJ; Lloyd-Jones D; Smith S
    J Am Coll Cardiol; 2016 Jan; 67(1):119-20. PubMed ID: 26764076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.